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Abstract
Stroke is one of the leading causes of death and disability across the world. With 
the development of new modalities of treatment, including the use of intravenous 
tissue plasminogen activator and mechanical thrombectomy, clinical outcomes have 
improved in patients with acute ischemic strokes. However, these interventions 
are time dependent, and there exists a great disparity between the rural and urban 
parts of the world in terms of the availability of neurologists and these lifesaving 
treatment options. Telestroke networks utilize digital technology for two-way, high-
resolution video teleconferencing to help abate these disparities by bringing safe, 
efficient, and cost-effective care to underserved communities in the United States 
and around the world.
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1. Introduction
In the United States (US), stroke is the fifth leading cause of mortality with a 
stroke occurring approximately every 40 seconds and stroke-related death approxi-
mately every 4 minutes [1, 2]. In 2011, stroke was found to be the leading cause of 
disability in the US, with around 7 million stroke survivors [3]. In 2016, the World 
Health Organization designated stroke as the second leading cause of mortality 
worldwide. Acute ischemic strokes account for about 80% of all stroke-related 
deaths [4]. Intravenous tissue plasminogen activator (tPA) has been shown to 
improve outcomes in acute ischemic stroke [5, 6]. In patients who receive tPA, early 
administration has been shown to reduce morbidity, mortality, and adverse events 
such as intracranial hemorrhages, promoting early discharges and higher rates of 
independent ambulation at discharge [5, 7]. Mechanical thrombectomies performed 
by neuro-interventionists have shown to improve outcomes for patients with proxi-
mal intracranial arterial occlusion [8–11] and have become the standard of care for 
patients who qualify for intervention. However, this procedure is performed only at 
tertiary care centers and is not available at smaller hospitals around the country.
Despite the obvious benefits of tPA administration, only a small percentage of 
patients presenting with acute ischemic strokes are eligible to receive it [12–15]. 
The most common reason attributed to this is a delay between the development of 
stroke symptoms and the patient seeking treatment at a hospital [16, 17]. There are 
also marked rural–urban disparities in stroke care [18–20]. These disparities are, 
Ischemic Stroke
2
in part, a result of the scarcity of neurologists [21–24]. Studies have shown better 
outcomes in stroke patients under the care of neurologists as compared to physi-
cians of other specialties, such as Internal Medicine or Family Medicine [22, 25, 26]. 
Telestroke aims to bridge this gap by providing neurology expertise in remote areas 
around the world through high-quality audio-video conferencing and digital image 
sharing.
2. Historical perspective
Communication of medical information across long distances has occurred 
throughout history. It is well documented that bonfires and heliographs were used 
to send communications about the bubonic plague in Europe [27]. Telegraph com-
munication was used in the civil war and radio communication was used in World 
War I, and wars thereafter, to send information about casualties and to request 
medical dispatches and transport for wounded soldiers [28]. Telemedicine in its 
current form was developed by NASA to monitor the physiologic states of astro-
nauts during manned space missions [29]. The first interactive video telemedicine 
systems were established for psychiatry [30] and radiology [31] but later expanded 
to critical care [32] and oncology [33] to bridge the shortage of specialists in these 
fields. In 1999, the term telestroke was first coined by Levine and Gorman, who 
described the use of video telecommunications as a means to facilitate cerebrovas-
cular consults to remote areas adding great expertise to the care of stroke patients 
[34]. Since then the number of telestroke networks around the world has expanded 
significantly [35–38].
3. Telestroke models
Before discussing telestroke models, it is important to understand the terminol-
ogy used to describe telestroke systems, as described by the American Telemedicine 
Association [39].
1. Distant site: the distant telestroke provider location.
2. Originating site: the site where the patient is initially located.
3. Telestroke network: a group of primary, secondary, and tertiary care settings 
that provide acute stroke care to patient populations. Telestroke networks con-
sist of originating sites where the patients are located and distant sites where 
the telestroke provider is located.
4. Spoke: the affiliate or partner site in a telestroke network that is underserviced 
or under-supported by neurologists where patient services are delivered.
5. Hub: a comprehensive tertiary care center where vascular neurologists and 
other acute stroke specialists compose a call panel delivering telestroke servic-
es to network partner sites (i.e., spoke sites). This is also the center where the 
patient may be transferred if a higher level of care is needed.
Several different telestroke models have been described and are listed below [38, 39].
1. Hub and spoke within a single healthcare system.
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2. Hub and spoke with external sites.
3. Horizontal hubless network: interconnected sites within a large hospital system 
for on-call clinical coverage.
4. Third-party distribution model: telestroke services are provided to multiple 
originating sites through arrangements with an independent corporation or an 
affiliated network of telestroke providers.
5. Supervisory training model: academic teleneurology programs to assist train-
ees within the hospital system.
Hub and Spoke with external sites and third-party distribution models are the 
most commonly used models within telestroke [35]. In telestroke networks, the 
majority of spoke sites are small hospitals (i.e., 0–99 beds) [37], but the spoke 
hospital size may vary from 25 to 500 beds in different telestroke networks [17]. 
A telestroke consult typically starts with a patient presenting to a spoke site with 
a suspected stroke. After an initial assessment by the physician at the spoke site, 
a triage process is conducted through telephone operators, followed by a video 
teleconferencing call with the neurologist at the distant site [see flow diagram of 
a telestroke system]. After reviewing the National Institute of Health Stroke Scale 
(NIHSS) and brain imaging (typically a non-contrasted CT scan of the head) and 
reviewing the patient’s history for indications/contraindications for tPA, a decision 
is made for administration of tPA. After this initial process, the decision of trans-
ferring the patient to the hub site is made, depending upon the need for further 
investigation, possible thrombectomy/neurosurgical intervention, or requirement 
of a higher level of care as compared to the spoke site. The term “Drip and Ship” is 
often used to describe transfer from spoke to hub sites, where after receiving the 
bolus dose of tPA, the patient is started on tPA drip and transferred emergently for 
further management [40].
The majority of the hospitals in telestroke systems have formal written contracts 
between the hub and the spoke site with a closed-loop communication system in 
place [37]. A vast array of Food and Drug Administration (FDA) approved two-way 
video-conferencing modalities with picture archiving and communication system 
are available for use by these networks that provide Health Insurance Portability 
and Accountability Act (HIPPA) compliant, secure, encrypted multipoint data 
sharing with evolving functionality through the use of desktops, robotic carts, lap-
tops, tablets, and even mobile phones with provider-to-provider interfaces [37, 38].
More recent advancements in telestroke systems include an ambulance-based 
telemedicine system that provides a feasible tool for prehospital stroke assessment 
[41–44]. Early attempts at prehospital telestroke consults were limited due to techni-
cal difficulties [44]. Newer studies have shown a high level of agreement in evaluation 
and treatment by mobile stroke units with a vascular neurologist on board compared 
to telestroke consults by a vascular neurologist [45] at a distant site who guides 
immediate treatment [46]. The data, however, is still limited and requires further 
investigation before the utility and efficacy of telestroke programs can be ascertained.
4.  Effectiveness and utility of telestroke in management of acute 
ischemic stroke
The primary goal of telestroke models is to establish a network of neurology 
consults across underserved areas that do not have in-house neurology consultants 
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available, thereby expediting the initial stroke exam and care. As the effective tPA 
window is time-sensitive, and early administration of tPA is known to improve out-
comes [5, 6, 13, 47], delay in transport of patients to tertiary care centers can lead to 
loss of the crucial intervention time window in acute ischemic stroke patients. After 
adequate training, the use of telestroke systems to measure NIHSS scores is viable 
and scoring is reliable, with inter-rater reliability comparable to that of in-person 
measurements [48, 49] even in telemedicine-naïve stroke practitioners [50]. Such 
assessment has also been found to be reliable when performed by neurology trained 
nurse practitioners [51], on laptop-based workstations [52], or even mobile-based 
video telestroke consults [53, 54]. Also, the FDA has approved teleradiology systems 
that enable effective and rapid evaluation of images by stroke specialists [55]. 
Stroke specialist evaluation via teleradiology systems has been found to be com-
parable to assessment by a neuroradiologist in aiding the decision making for tPA 
administration [56, 57].
Studies have shown that telestroke facilitated administration of tPA to patients 
in community hospitals and rural hospitals (as small as 100 beds or less) has 
outcomes comparable to those of in-person treatment at comprehensive stroke care 
centers [58–61]. Even with in a stroke network, the performance of spoke sites is 
similar regardless of the bedsize [62]. Also, the use of telestroke at rural hospitals 
can provide patients with comparable or reduced time between symptom onset 
and tPA administration [door-to-needle time (DTN)] compared to those directly 
presenting to tertiary care centers [63]. A non-blinded randomized control trial 
in the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) network in 
Germany showed that patients treated in telestroke network hospitals had signifi-
cantly fewer poor outcomes compared to patients treated in community hospitals 
without telestroke capabilities [64]. Telestroke consults are becoming exceedingly 
cost-effective in dealing with acute strokes in the community [65–69].
5. Telestroke for post-tPA care and work up
Telestroke consults also have utility beyond acute stroke. Patients receiving 
tPA or those with subacute strokes with milder symptoms not requiring emergent 
intravascular intervention can remain at the spoke site for further investigation. 
Telestroke follow-up consults can aid in guiding the physicians at the spoke sites 
to continue further stroke workup and discharge patients from the spoke site. This 
may also reduce the cost of transport and limit patients being transferred to hub 
sites to only those requiring urgent neurosurgical/intravascular intervention. A ran-
domized control trial by Evans et al. showed that the management of stroke patients 
in dedicated stroke units showed better outcomes for large vessel infarcts but not for 
small lacunar infarcts when compared to those in general medical wards with stroke 
team support [70]. Based on this hypothesis, small lacunar strokes could potentially 
be managed by the medical team at spokes sites with telestroke consults and follow-
ups. The Telemedicine in Stroke in Swabia Project and The Order of St. Francis 
Stroke Network study experience demonstrated the safety and reliability of such 
telestroke models [71, 72]. Even for patients requiring treatment in an intensive 
care unit, teleneurointensive care units are providing valuable support for preven-
tion, diagnosis, and the timely management of cerebrovascular conditions induced 
secondary to neurologic injuries [73] and have shown improved outcomes [74].
Telestroke has also been studied in in-home and ambulatory post-stroke 
rehabilitation settings for serial neurologic assessments and timely adjustments 
of therapies. These studies have shown that telerehabilitation approaches are 
comparable to conventional rehabilitation in improving activities of daily living and 
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motor function for stroke survivors [75, 76]. Virtual neurovascular clinics aimed 
at secondary stroke prevention are another evolving avenue for follow-up visits for 
stroke patients [77].
In the field of clinical research, telestroke consults may aid in identifying 
patients who are eligible for trials of therapies for ischemic or hemorrhagic 
strokes, neuroprotective agents, or innovative diagnostic tests, thereby facilitating 
expedited enrollment at the originating sites after transfer to stroke centers [78]. 
Telestroke models are being incorporated into the education and training of neu-
rologists, emergency teams, and nursing staff [77, 79–82]. With the ever-expanding 
horizons of telestroke, training in telemedicine will likely become mainstream for 
all future physician and medical personnel training programs. However, the data 
regarding the use of telestroke beyond acute stroke care is still limited and needs 
further investigation.
6. Telestroke outcomes and cost-effectiveness
Zaidi et al. showed that outcomes at 90 days were no different between patients 
treated with tPA by telemedicine and patients treated by the same neurologists over 
the same time interval at the stroke center hub hospital [83]. They also found no 
difference in time from stroke onset to treatment. Switzer et al. found that the aver-
age time between symptom onset and treatment at the spoke sites in their telestroke 
system was lower than the emergency department at their hub site [63]. As previ-
ously mentioned, several studies have found post-tPA outcomes at spoke sites were 
comparable to those of in-person treatment at comprehensive stroke care centers 
[58–61]. Implementation of a standardized regional telestroke program in a com-
munity setting increased utilization of alteplase, improved DTN time, decreased 
length of stay, and significantly increased the chances of patients going home [84].
Establishing a telestroke network requires infrastructure and technology-related 
expenses along with the expenses of round-the-clock neurology coverage and the 
cost of transport. Initial projects around the country were supported by govern-
ment funds and research grants, but to develop a self-sustaining model, telestroke 
networks need to be cost-effective. For a Danish telestroke system consisting of five 
hubs and five spokes, a 2008 study by Ehlers et al. calculated an incremental cost-
effectiveness ratio (the cost of thrombolysis per quality-adjusted life year [QALY]) 
to be approximately US$50,000 after 1 year [69]. In 2011, Nelson et al. conducted 
cost data analyses of telestroke networks in rural Arizona and Utah and found the 
incremental cost-effectiveness ratio using a 90-day horizon of $108,363 per QALY 
and a lifetime horizon of $2449 per QALY [66], which reflected a high initial cost 
but overall long-term cost reduction, likely due to rehabilitation cost reduction from 
early tPA administration. Also, the highest cost-effectiveness was seen in the most 
severe stroke cases. In a 2013 study by Switzer et al., cost savings of $358,435 per 
year over 5 years were observed in a telestroke system consisting of one hub and 
seven spokes, as well as an improvement in patients’ quality of life associated with 
increased numbers of individuals being discharged to home [67]. Growing evidence 
for the cost-effectiveness of telestroke networks and improved patient outcomes has 
spurred the growth of telestroke networks around the world.
7. Telestroke quality measures
Continuous quality improvement is a key element for any successful telestroke 
program. Several elements play a role in this improvement, including adaptation to 
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local laws and statues, effective training programs, identification of competency 
issues, and overcoming challenges with technical and manpower issues at both 
provider and recipient sites. In 1988, Donebedian was the first to describe the model 
of structure, process, and outcomes measurements for assessing the quality of 
healthcare [85]. Systematic collection and analysis of quality data has been shown to 
improve the quality of stroke care that is delivered [86], and telestroke is no excep-
tion to this. Several quality measures help assess and quantify the overall function 
of telestroke systems. Most hub hospitals have stroke certification and emergency 
and ICU staff training through standards set by the Joint Commission on the 
Accreditation of Healthcare Organizations (JCAHO) process.
7.1 Structural measures
The capacity of the healthcare system, staffing ratios of specialists, availability 
of specialized units and equipment, and the organization structure with hospital 
networking should all be carefully studied and analyzed for any telehealth network 
systems. Defined protocols should be in place both at the originating and distant 
sites.
7.2 Process measures
Analogous to the traditional stroke pathway, the key global component of 
telestroke quality is still DTN time. Median DTN with telestroke varies from 
106 to 121 minutes, even though the recommendation is less than 1 hour [58]. 
Several aspects of stroke chain-of-care that play an important role in DTN include 
Emergency Department (ED) door to CT scan (D-CT) time, ED door to teleneur-
ologist consult time, teleneurologist to camera/phone time, and teleconsult dura-
tion (Con).
Clear definitions of these times are important as no uniform definitions cur-
rently exist. In some centers, a consult with teleneurologist occurs after CT scan 
results are obtained, while in other centers, a consult is initiated even before the 
CT scan is ordered. The time from ED to consult differs in these situations, which 
can affect these measures. Similarly, the definition of consult time varies between 
centers. At some centers, consult time is defined as the time spent on camera evalu-
ating patients, and at other centers, it is defined as time spent on camera along with 
the time spent reviewing the images and other diagnostic results. Because of these 
variations, consult duration varied from 14 to 32 minutes in different studies [87, 
88]. Studies showed that telestroke by itself might not decrease the DTN as there are 
variations in the subsects of stroke chain-of-care [89].
It has been shown that D-NC and Con play a major role in DTN [90]. Various 
factors including, when the consultant is notified, the time a consultant takes to 
interview the patient, and the experience level of the staff aiding with the exami-
nation will have to be considered while analyzing such data. The percentage of 
patients transferred after a telestroke consult to a destination hospital is also an 
important factor as it involves significant costs [67]. Data should be collected quan-
tifying the rate of transfers after the consult and steps should be taken to minimize 
unnecessary transfers.
7.3 Outcome measures
The success of any program is ultimately decided by measuring outcomes, 
which could be patient related or system related. A modified Rankin scale, which 
is measured 90 days after a stroke, is the most commonly used measurement of 
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stroke outcome [83]. Steps should be taken to ensure a 90-day follow-up on all the 
telestroke treated patients. No significant differences in mortality or morbidity were 
noted in patients in the hub and spoke hospitals of the TEMPiS network [91]. Even 
though 90-day outcomes after stroke are reported in most clinical trials, this data 
is not routinely collected by hospitals because of the cost and complexity involved. 
Data on stroke mimics that were treated by telestroke networks is an important fac-
tor as it plays a big role in minimizing costs, even though tPA administration might 
not increase the risk to these patients. Similarly, data on the percentage of patients 
receiving tPA through telestroke networks is very useful to compare with in-person 
stroke treatment numbers. In a study that examined several telestroke networks, 
the rate of tPA via telestroke was 18–36% compared to the national average tPA 
administration rate of 5–8% [91].
7.4 Patient/provider-related outcomes
Data collection regarding patient characteristics, NIHSS score pre/post-treat-
ment and before discharge, length of hospital stay, discharge disposition (home vs. 
rehab vs. sub-acute rehab), readmission rate, complications including intracranial 
hemorrhage, other significant hemorrhages, mortality, and 90-day follow-up 
outcomes are recommended by the American Heart Association and the American 
Stroke Association [92]. One of the highest priorities for several healthcare systems 
is patient satisfaction. Attempts should be made to follow-up with the treated 
patients and family members about their satisfaction with the telestroke process. 
LaMonte et al. found that the telestroke process enhanced patient satisfaction in 
their study [93]. Measuring provider satisfaction is equally important for improving 
telestroke service quality. Studies showed that patients are more enthusiastic about 
telemedicine compared to providers even though both of the groups were satisfied 
[94]. Providers having less of a personal benefit was one of the possible reasons 
behind this discrepancy [92].
7.5 Technological quality measures
In a good telestroke program, the technology involved is as important as the 
physicians’ clinical expertise. Video and audio conferencing equipment quality, 
transmission clarity, internet speed, user-friendliness of the software, accessibility 
of personnel training modules, and encryption of patient information in transit 
to protect patient privacy all play a role for effective delivery of telestroke care. All 
technical difficulties, failures, and limitations should be continuously monitored, 
documented, and analyzed promptly to prevent repeated occurrences.
Lastly, apart from the issues unique to telestroke, data on regular measures as 
recommended by National Quality Forum for stroke patients, including use of tPA, 
anti-thrombolysis therapy by day 2, thromboembolism prophylaxis, lipid-lowering 
medications on discharge, anti-thrombotic therapy on discharge, anticoagulation 
in the setting of atrial fibrillation, rehabilitation evaluation, and stroke education 
should be collected and evaluated regularly [95].
7.6 Quality measures: final thoughts
There are still challenges with current models. In the last 15 years, there has been 
a substantial improvement in stroke quality measures. Most of the measures are 
already being performed with a high compliance rate and innovation. They should 
be expanded to pre-hospitalization and post-hospitalization settings as well as to 
telestroke for further improvement of stroke care [62, 96–99]. Universal guidelines 
Ischemic Stroke
8
about definitions of times in stroke chain-of-care, protocols for consultant notifica-
tion, and specific standard stepwise processes that can be applied universally for 
telestroke networks will be useful in standardizing telestroke models. As telestroke 
is becoming more popular in delivering care for acute stroke patients, there is a 
need for strict quality metrics to ensure safe and effective care for the patients. Even 
though in several aspects telestroke is as effective as in-person stroke care, there are 
several issues pertinent to telestroke like technology, policies, and challenges with 
data collection due to distant participating sites that need to be refined for effective 
and timely management of stroke patients.
8. Telestroke across the world
Lack of neurology coverage is not unique to the US; it is a problem worldwide 
[100]. Several countries in Europe have developed efficient telestroke networks 
[59, 64, 69, 101–103], with the TEMPiS network in Germany showing remark-
able results [64, 104, 105]. The Telestroke Committee of the European Stroke 
Organization has recently published recommendations regarding telestroke 
networks in Europe concerning infrastructure, teleconsultation service, transfer 
options, standard operating procedures, professional training, and quality monitor-
ing and improvement. They have also made recommendations about the technical 
and ethical aspects of telemedicine [106], which are similar to ones in the US.
Asia is quite heterogeneous in terms of variability in language, governments, 
culture, historical links, socioeconomic development, and organization of health 
services. In China, the National Telestroke Center, established in 2014, was designed 
to provide neurological coverage to 300 rural hospitals throughout the country 
through the telestroke network [107]. This was also the first platform where Google 
Glasses were used for real-time telestroke consults. The system is still evolving and 
data from China is still limited. In India, telestroke systems are still uncommon, but 
they show prospects for expansion, aiming to provide care to rural communities 
that are limited in their resources [108, 109]. Japan, Singapore, and South Korea 
have rather advanced nationwide medical systems, but telemedicine experience in 
these countries is still limited [110–112]. Teleneurology and telestroke have great 
potential to extend neurology expertise to underserved populations in the world; 
however, further investment in creating infrastructure and technology is needed 
before their impact on healthcare is realized.
9. Telestroke in the new era of novel coronavirus (COVID-19)
In December 2019, the first case of the novel coronavirus COVID-19 was identi-
fied in China [113]. Since then, the rapid spread of the virus has led to a worldwide 
pandemic [114]. The US has become the epicenter of this pandemic with the largest 
number of reported cases worldwide. Of all COVID-19 cases, an estimated 19% are 
healthcare personnel [115]. The COVID-19 pandemic has put a significant strain 
on healthcare personnel in providing in-person care, especially in an acute setting. 
Several States in the US and countries around the world have implemented stay-at-
home orders. Hospitals have canceled elective procedures and outpatient in-person 
clinic visits to minimize the exposure risk to patients and healthcare workers. 
Additionally, COVID-19 is associated with an increased risk of thromboembolic 
complications [116]. This puts neurologists at risk of exposure while assessing 
patients with acute neurological deficits. Screening for symptoms of COVID-19 has 
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also become difficult in the setting of neurological deficits, especially aphasia and 
encephalopathy. Most countries around the world, including the US, already suffer 
from a lack of adequate neurology coverage [100] and COVID-19 exposure not only 
puts neurologists’ wellbeing and life at risk but also exacerbates this deficiency. 
This pandemic has brought the need and utility of telemedicine, teleneurology, and 
telestroke into the limelight [117–120]. Teleconsults are an effective way of provid-
ing outpatient care as well was acute care inside the hospitals, limiting the exposure 
risk to physicians and patients, as well as limiting the use of personal protective 
equipment which is in short supply. The pandemic may change the paradigm of 
teleneurology and telestroke permanently and force the system to adapt to its 
growing need at a much faster pace.
10. Hurdles and barriers
Despite the utility and efficacy of telestroke networks, there exist significant 
hurdles in establishing and efficiently sustaining a viable telestroke program.
10.1 Issues regarding reimbursement
The most important hurdle is third party reimbursement. It took decades for 
the concept of telemedicine to come to fruition, and pay parity kept telemedi-
cine programs across the country from flourishing, sustaining, and expanding 
[121–126]. Without appropriate reimbursement, the burden of financial overhead 
in maintaining the high-quality video interface, teleneurology and teleradiology 
coverage, and costs of emergent care including imaging, tPA, and transportation 
to hub hospitals would make telestroke network unsustainable. The Centers for 
Medicare and Medicaid Services (CMS) has addressed the need for reimburse-
ment for telemedicine services and third-party payers have followed suit [37, 121]. 
Appropriate reimbursement for teleservices remains a concern among providers 
[127] and continues to be a barrier for the expansion of telestroke networks to 
underserved areas of the country.
10.2 Licensure and credentialing constraints
Licensure and hospital credentialing, often across state lines, further burdens 
physicians and hospitals to spend resources, thus putting additional constraints 
on the expansion of these services. Physicians are required to maintain a license 
in the state where the spoke site is located in addition to the hub site where they 
usually work. This requires unrestricted licensure to be maintained in every state 
where the teleconsult is requested. A national or multistate license for tele-
medicine would reduce the necessity for a consultant to be licensed in multiple 
individual states, but this kind of license does not currently exist [128]. In 2011, 
CMS began allowing credentialing and privileging by proxy at small and critical-
access hospitals, which has allowed these hospitals to rely on the credentialing 
and privileging process performed at the hub site [92, 129]. However, this policy 
needs to be adopted by all 50 states to mitigate the onus of licensing and creden-
tialing on physicians and small hospitals. Also, reimbursement in cases where 
the patient receives tPA at the spoke site and is transferred to the hub hospital 
remains an issue, as neither the spoke nor hub facility is eligible to bill the higher 
Medicare diagnosis-related group codes that are associated with thrombolytic 
administration [128].
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10.3 Infrastructure and technological challenges
Establishing and maintaining the infrastructure for high-quality video conferenc-
ing in small rural hospitals also adds to the financial burden on these hospitals. There 
is also marked heterogeneity in the platforms available, which spoke sites need to 
take into account before joining a telestroke model [37, 128]. Platform differences 
also limit the flexibility of these rural hospitals in terms of associating with more 
than one network or transitioning to a different network as the platforms utilized 
by these networks may be incompatible. Additionally, to comply with CMS billing 
requirements, a high-quality, two-way video connection is recommended and a 
minimum frame rate of at least 20 frames per second has been suggested [130]. Thus, 
high-speed internet is an essential component of telestroke networks. The availability 
of high-speed internet connections in rural parts of the country is limited and is a 
separate problem limiting the implementation of telestroke networks. These issues 
become exceedingly challenging in resource-limited countries around the world.
10.4 Physician buy-in and telestroke staff training
Convincing the leadership of potential spoke sites of the cost-effectiveness of 
joining a telestroke system requires time and effort on the part of the hub telestroke 
providers. Joining a telestroke system not only requires investment in infrastructure 
but also requires extensive training and development of protocols for teleconsults 
and transfers. These requirements may appear daunting to the leadership and 
hospital staff, especially at small rural hospitals with limited resources. However, 
the literature supporting the safety, cost-effectiveness, and improved patient 
outcomes related to telestroke networks may help encourage their buy-in to such 
programs. Joining such a system implies a long-term partnership between the hub 
and the spoke sites. Trust also needs to be established between the spoke site ED 
staff and consulting neurologists. Endorsements and testimony from the leadership 
of existing spoke sites in similar settings, hearing patient experiences from those 
who benefitted from these networks, and meeting with the team of consulting 
neurologists may prove useful in building this trust.
Along with the establishment of infrastructure for telestroke, medical staff 
at spokes sites need to be trained for ever-evolving telestroke protocols and joint 
commission requirements. They need to be able to recognize the early signs and 
symptoms of acute stroke, perform NIHSS exams, screen for eligibility for tPA, 
and to be proficient at using the teleconsult interface to facilitate the process 
efficiently. Telestroke systems can include stroke patient management training to 
spoke medical staff on education NIHSS exam demonstrations, reviews of alteplase 
reconstitution, administration and considerations, alteplase dosage calculations 
and telemedicine cart demonstration and review. Other patient management train-
ing can be provided to paramedics local to the spoke sites, these sessions typically 
include; impact of and time sensitivity of strokes, what is a stroke, types of stroke, 
stroke mimics, EMS neurological assessments, stroke management/prehospital 
guidelines and telemedicine and alteplase through an organizational system of care.
Given the wide variability of telestroke systems based on AHA/ASA guidelines 
and local governing factors, each network should develop an standard operating 
protocol (SOP) that suits their needs (Tables 1–3) [131]. The volume of teleconsults 
can vary greatly between the spoke hospitals, thus training needs to be reinforced 
at specified intervals to ensure efficient and seamless consults and to maintain 
high-quality patient care. This may lead to telemedicine fatigue in the staff at low-
volume hospitals that needs to be mitigated during the training by emphasizing the 
importance of their work in the teleconsult system in their community at improving 
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outcomes in patients who may have otherwise not had an opportunity for timely 
stroke intervention due to time lost in transportation to larger centers.
10.5 Data security and sharing
Telestroke networks, like traditional practices, are required to be compliant with 
HIPAA, which governs protected health information in the US. Given that telestroke 
American College of Cardiology/American Heart Association class of recommendation and level of 
evidence to clinical strategies, interventions, treatments, or diagnostic testing in patient care*
Class (strength) of recommendation
Class I (strong)—benefit >>> risk
Suggested phrases for writing recommendations:
• Is recommended
• Is indicated/useful/effective/beneficial
• Should be performed/administered/others
• Comparative-effectiveness phrases†:
 ○ Treatment/strategy A is recommended/indicated in preference to treatment B
 ○ Treatment A should be chosen over treatment B
Class IIa (moderate)—benefit >> risk
Suggested phrases for writing recommendations:
• Is reasonable
• Can be useful/effective/beneficial
• Comparative-effectiveness phrases†:
 ○ Treatment/strategy A is probably recommended/indicated in preference to treatment B
 ○ It is reasonable to choose treatment A over treatment B
Class IIb (weak)—benefit ≥ risk
Suggested phrases for writing recommendations:
• May/might be reasonable
• May/might be considered
• Usefulness/effectiveness is unknown/unclear/uncertain or not well established
Class III: no benefit (moderate) (generally, LOE A or B use only)—benefit = risk
Suggested phrases for writing recommendations:
• Is not recommended
• Is not indicated/useful/effective/beneficial
• Should not be performed/administered/others
Class III: harm (strong)—risk > benefit
Suggested phrases for writing recommendations:
• Potentially harmful
• Causes harm
• Associated with excess morbidity/mortality
• Should not be performed/administered/others
*The outcome or result of the intervention should be specified (an improved clinical outcome or increased diagnostic 
accuracy or incremental prognostic information).
†For comparative-effectiveness recommendations (COR I and IIa; LOE A and B only), studies that support the use of 
comparator verbs should involve direct comparisons of the treatments or strategies being evaluated.
Table 1. 
American Heart Association summary of recommendations for telestrokes [131].
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networks rely on real-time data sharing between the spoke and the hub, data security 
becomes a concern. Data security requires end-to-end encryption on the sharing 
platform, reliable documentation and storage, strict control of access to users within 
Level A
• High-quality evidence‡ from more than one randomized controlled trial (RCT)
• Meta-analyses of high-quality RCTs
• One or more RCTs corroborated by high-quality registry studies
Level B-R (randomized)
• Moderate-quality evidence‡ from one or more RCTs
• Meta-analyses of moderate-quality RCTs
Level B-NR (nonrandomized)
• Moderate-quality evidence‡ from one or more well-designed, well-executed nonrandomized studies, 
observational studies, or registry studies
• Meta-analyses of such studies
Level C-LD (limited data)
• Randomized or nonrandomized observational or registry studies with limitations of design or execution
• Meta-analyses of such studies
• Physiological or mechanistic studies in human subjects
Level C-EO (expert opinion)
• The consensus of expert opinion based on clinical experience
Class of recommendation (COR) and level of evidence (LOE) are determined independently (any COR may be 
paired with any LOE). A recommendation with LOE C does not imply that the recommendation is weak. Many 
important clinical questions addressed in guidelines do not lend themselves to clinical trials. Although RCTs are 
unavailable, there may be a very clear clinical consensus that a specific test or therapy is useful or effective.
‡The method of assessing quality is evolving, including the application of standardized, widely used, and preferably 
validated evidence grading tools; and for systematic reviews, the incorporation of an Evidence Review Committee.
COR, class of recommendation; EO, expert opinion; LD, limited data; LOE, level of evidence; NR, nonrandomized; 
R, randomized; and RCT, randomized controlled trial.
Table 2. 
Level (quality) of evidence‡ [131].
Telemedicine COR LOE
1. For sites without in-house imaging interpretation expertise, teleradiology systems 
approved by the US Food and Drug Administration are recommended for timely 
review of brain imaging in patients with suspected acute stroke.
I A
2. When implemented within a telestroke network, teleradiology systems approved 
by the US Food and Drug Administration are useful in supporting rapid imaging 
interpretation in time for IV alteplase administration decision making.
I A
3. Telestroke/teleradiology evaluations of acute ischemic stroke (AIS) patients can 
be effective for correct IV alteplase eligibility decision making.
IIa B-R
4. Administration of IV alteplase guided by telestroke consultation for patients with 
AIS may be as safe and as beneficial as that of stroke centers.
IIb B-NR
5. Providing alteplase decision-making support via telephone consultation to 
community physicians is feasible and safe and may be considered when a hospital 
has access to neither an in-person stroke team nor a telestroke system.
IIb C-LD
6. Telestroke networks may be reasonable for triaging patients with AIS who 
may be eligible for interfacility transfer to be considered for acute mechanical 
thrombectomy.
IIb B-NR
Table 3. 
American Heart Association/American Stroke Association guidelines for telemedicine [131].
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the network, and cooperation between the information technology staff at both sites. 
To ensure 24-hour coverage, consulting physicians often use a mobile device for such 
calls and must be cognizant of their surroundings while consulting remotely. For 
example, most telestroke systems provide home accessibility for physician consults. 
Currently due to HIPPA rules the use of hand held mobile phones remains limited 
for detection of stroke. Given the renewed interest in telehealth with the COVID-19 
pandemic, there is a potential for use of mobile phone application technology.
Healthcare data breaches have been on the rise with larger and teaching hospitals 
being at a greater risk [132, 133]. Given multiple points of entry and the potential 
for data breaches in telestroke networks, extra care is needed at the hub and spokes 
sites to ensure data safety. Despite these challenges, telestroke networks have shown 
to provide safe, efficient, and cost-effective stroke care to underserved communi-
ties. There is still enormous potential for telestroke networks to expand into rural 
areas of the country as well as around the world.
11. Conclusion
Since its conception, telestroke has expanded greatly in its scope and utility in 
bridging the gap in stroke care between the rural and urban communities, in both 
acute and continued care. Despite the challenges faced in establishing and sustaining 
telestroke networks, these networks are flourishing and expanding, creating an ever-
evolving paradigm for stroke care throughout the country and around the world.
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